p38 MAPK and JNK antagonistically control senescence and cytoplasmic p16INK4A expression in doxorubicin-treated endothelial progenitor cells (Q33781038)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | p38 MAPK and JNK antagonistically control senescence and cytoplasmic p16INK4A expression in doxorubicin-treated endothelial progenitor cells |
scientific article |
Statements
1 reference
p38 MAPK and JNK antagonistically control senescence and cytoplasmic p16INK4A expression in doxorubicin-treated endothelial progenitor cells (English)
1 reference
Claudio Brunelli
1 reference
Paola Altieri
1 reference
Paolo Spallarossa
1 reference
Concetta Aloi
1 reference
Giuseppina Fugazza
1 reference
Marco Canepa
1 reference
20 December 2010
1 reference
1 reference
12
1 reference
e15583
1 reference
20 December 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference